Table 2. Concurrent therapies individuals received during nimotuzumab treatment.
Concurrent therapy | Severe | Moderate | Total | |||
---|---|---|---|---|---|---|
n | % | n | % | n | % | |
Recombinant IFN-α | 0 | 0 | 3 | 30 | 3 | 7.3 |
Low-molecular-weight heparin | 30 | 96.8 | 4 | 40 | 34 | 82.9 |
Steroids | 28 | 90.3 | 3 | 30 | 31 | 75.6 |
Antibiotics | 30 | 96.8 | 10 | 100 | 40 | 97.6 |
CIGB-258 | 12 | 38.7 | 1 | 10 | 13 | 31.7 |